Suk Woo Kang

Dr. Suk Woo Kang

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2019 in Catalysts
Verified
Journal Article
Open access
PDF file
MSMihir V. Shah
Mihir V. Shah
JAJames Antoney
James Antoney
SKSuk Woo Kang
Suk Woo Kang
AWAndrew Warden
Andrew Warden
CHCarol Hartley
Carol Hartley
CSColin Scott
Colin Scott
The asymmetric reduction of enoates, imines and ketones are among the most important reactions in biocatalysis. These reactions are routinely conducted using enzymes that use nicotinamide cofactors as reductants. The deazaflavin cofactor F420 also has electrochemical properties that make it suitable as an alternative to nicotinamide cofactors for use in asymmetric reduction reactions. However, cofactor F420-dependent enzymes remain under-explored as a resource for biocatalysis. This review considers the cofactor F420-dependent enzyme families with the greatest potential for the discovery of new biocatalysts: the flavin/deazaflavin-dependent oxidoreductases (FDORs) and the luciferase-like hydride transferases (LLHTs). The characterized F420-dependent reductions that have the potential for adaptation for biocatalysis are discussed, and the enzymes best suited for use in the reduction of oxidized cofactor F420 to allow cofactor recycling in situ are considered. Further discussed are the recent advances in the production of cofactor F420 and its functional analog FO-5′-phosphate, which remains an impediment to the adoption of this family of enzymes for industrial biocatalytic processes. Finally, the prospects for the use of this cofactor and dependent enzymes as a resource for industrial biocatalysis are discussed.

27 December 2017 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
SKSuk Woo Kang
Suk Woo Kang
KKKyung-A. Kim
Kyung-A. Kim
CLChung Hyun Lee
Chung Hyun Lee
SYSung Jae Yang
Sung Jae Yang
TKTae Kyeom Kang
Tae Kyeom Kang
SJSang Hoon Jung
Sang Hoon Jung

2 April 2014 in European Food Research and Technology
Verified
Journal Article
Closed access
PDF file
SKSuk Woo Kang
Suk Woo Kang
Kyungsu KangKyungsu Kang
Kyungsu Kang
MKMi Ae Kim
Mi Ae Kim
NJNa Ra Jeon
Na Ra Jeon
Sang Min KimSang Min Kim
Sang Min Kim
BUByung-Hun Um
Byung-Hun Um

25 April 2025 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
TLTam Thi Le
Tam Thi Le
STSon Hung Tran
Son Hung Tran
SLSohyun Lee
Sohyun Lee
SKSuk Woo Kang
Suk Woo Kang
JKJi Hoon Kim
Ji Hoon Kim
SJSang Hoon Jung
Sang Hoon Jung

11 April 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
NNNgoc Bao Nguyen
Ngoc Bao Nguyen
TLTam Thi Le
Tam Thi Le
SKSuk Woo Kang
Suk Woo Kang
KCKwang Hyun Cha
Kwang Hyun Cha
SCSowoon Choi
Sowoon Choi
MKMyungsuk Kim
Myungsuk Kim
Sarcopenia, a decline in muscle mass and strength, can be triggered by aging or medications like glucocorticoids. This study investigated cornflower (Centaurea cyanus) water extract (CC) as a potential protective agent against DEX-induced muscle wasting in vitro and in vivo. CC and its isolated compounds mitigated oxidative stress, promoted myofiber growth, and boosted ATP production in C2C12 myotubes. Mechanistically, CC reduced protein degradation markers, increased mitochondrial content, and activated protein synthesis signaling. Docking analysis suggested cannabinoid receptors (CB) 1 and 2 as potential targets of CC compounds. Specifically, graveobioside A from CC inhibited CB1 and upregulated CB2, subsequently stimulating protein synthesis and suppressing degradation. In vivo, CC treatment attenuated DEX-induced muscle wasting, as evidenced by enhanced grip strength, exercise performance, and modulation of muscle gene expression related to differentiation, protein turnover, and exercise performance. Moreover, CC enriched gut microbial diversity, and the abundance of Clostridium sensu stricto 1 positively correlated with muscle mass. These findings suggest a multifaceted mode of action for CC: (1) direct modulation of the muscle cannabinoid receptor system favoring anabolic processes and (2) indirect modulation of muscle health through the gut microbiome. Overall, CC presents a promising therapeutic strategy for preventing and treating muscle atrophy.

8 March 2023 in ChemBioChem
Verified
Journal Article
Open access
SKSuk Woo Kang
Suk Woo Kang
JAJames Antoney
James Antoney
DLDavid W. Lupton
David W. Lupton
RSRobert Speight
Robert Speight
CSColin Scott
Colin Scott
CJColin J. Jackson
Colin J. Jackson
Asymmetric reduction by ene‐reductases has received considerable attention in recent decades. While several enzyme families possess ene‐reductase activity, the Old Yellow Enzyme (OYE) family has received the most scientific and industrial attention. However, there is a limited substrate range and few stereocomplementary pairs of current ene‐reductases, necessitating the development of a complementary class. Flavin/deazaflavin oxidoreductases (FDORs) that use the uncommon cofactor F420 have recently gained attention as ene‐reductases for use in biocatalysis due to their stereocomplementarity with OYEs. Although the enzymes of the FDOR‐As sub‐group have been characterized in this context and reported to catalyse ene‐reductions enantioselectively, enzymes from the similarly large, but more diverse, FDOR‐B sub‐group have not been investigated in this context. In this study, we investigated the activity of eight FDOR‐B enzymes distributed across this sub‐group, evaluating their specific activity, kinetic properties, and stereoselectivity against α,β‐unsaturated compounds. The stereochemical outcomes of the FDOR‐Bs are compared with enzymes of the FDOR‐A sub‐group and OYE family. Computational modelling and induced‐fit docking are used to rationalize the observed catalytic behaviour and proposed a catalytic mechanism.